Concerns about HAART (Highly Active Anti-Retroviral Therapy)

Alberta Reappraising AIDS Society
David R. Crowe, President
Phone: +1-403-289-6609
Fax: +1-403-206-7717
Email: David.Crowe@aras.ab.ca

Roger Swan, Treasurer
Box 61037, Kensington Postal Outlet
Calgary, Alberta T2N 4S6
Canada
Office
Phone: +1-403-220-0129
Email: aras@aras.ab.ca
Web: noaids.ca

Concerns about HAART (Highly Active Anti-Retroviral Therapy)

Nevirapine

Nevirapine (also known as Viramune) is a very popular non-nucleoside reverse transcriptase inhibitor and only the second drug, after AZT, approved (in some countries) for prevention of mother-to-child transmission of HIV. It is also fearsomely toxic. Read and weep.

Feedback

We appreciate your comments, feedback, questions and suggestions for improvements to this site. Click here to send us a message.

© Copyright February 15, 2016: Alberta Reappraising AIDS Society